Uptrend
Dist4
PURR

PURR

Hyperliquid Strategies Inc

$12.18-4.62%
Setup
Watch
Buy Zone
$11.99-$12.59
Sector
Capital Markets
Industry
Capital Markets
71
Recommendation
Extended
Hold

Setup may be valid but price is no longer in a clean buy zone.

PURR chart

Loading chart…
Overall Quality71
50
relative strength
97
Strong fund-Q
68
+71% vs avg
50
4/8 checks
91
Capital Markets

Trade Plan

Extended
Entry
$11.99
Entry Zone
$11.99-$12.59
Stop / Risk
$11.03
RS Rating
50
Volume confirmed
No
Targets
$14.39 / $14.99

Breakout · IBD Setup

3 5
Entry $11.99–$12.59Stop $11.03Target $14.39 / $14.99
Market regimeUptrend
Quality71
RS Rating50
Above 50-MA+48.04%
Above 200-MA+94.4%
VolumeWeak
In Buy ZoneNo
Not extendedExtended
Invalidation · Close below stop

How this came together

71
MarketUptrend
SetupWatch
ConfidenceExperimental · not backtested
Fund-Q97 · Strong
StatusHold

Stock Data

52-Week Range3 – 14
Price % Chg YTD242.13%
Price % Chg 4wk82.61%
50-Day Avg Vol16.0 Mil
P/E Ratio18.8
Market Cap$2B
SectorFinancial
IndustryCapital Markets

Company Fundamentals

EPS % Chg (Qtr)43889.58%
Sales % Chg (Qtr)
EPS Growth 5y
Sales Growth 5y
Annual ROE33.94%
Gross Margin
Operating Margin-60.1%
Net Margin2552.32%
Debt / Equity0.00

Setup levels

Current price
$12.18
Pivot
$11.99
Distance to buy
-13.9%
52-week range
3.01-14.14

Trigger evidence

No active trigger evidence available.
Financial health checks
4/4
Return on equity above 15%

ROE 33.94%

Net margin above 10%

Net margin 2552.32%

EPS growing quarter on quarter

EPS q/q 43889.58%

Debt to equity below 1.0

D/E 0.00

Key metrics

Finviz snapshot · value vs. sector median (≥5 peers)

Annual ROE33.94%
vs sector +19.8%
Net margin2552.32%
vs sector +2532.7%
Gross margin
EPS growth q/q43889.58%
vs sector +43857.1%
Sales growth q/q
Debt / equity0.00
vs sector -3.05

Business quality

97
GradeStrong
EPS rating99
P/E18.8
Market cap$2B
IndustryCapital Markets

Technical checks

Über 50-MA
Pass
Über 200-MA
Pass
RS-Linie auf neuem Hoch
Fail
Volumen bestätigt
Fail
In Kaufzone
Fail
Nicht überextended
Fail
Über 21-EMA
Pass
Volumen gesund
Pass

IBD / source mentions

No recent IBD mention found for this ticker.

Signal history

Added to list
2026-08-31
Trigger date
Days on list
7

Data sources: internal CANSLIM engine · Finviz snapshot · TradingView chart. Not investment advice.